Pfizer 2015 Annual Report Download - page 68

Download and view the complete annual report

Please find page 68 of the 2015 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 134

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134

Consolidated Statements of Comprehensive Income
Pfizer Inc. and Subsidiary Companies
2015 Financial Report
67
Year Ended December 31,
(MILLIONS) 2015 2014 2013
Net income before allocation to noncontrolling interests $6,986 $9,168 $22,072
Foreign currency translation adjustments, net $ (3,110) $(1,992)$ (535)
Reclassification adjustments(a) —(62)144
(3,110) (2,054)(391)
Unrealized holding gains on derivative financial instruments, net 204 24 488
Reclassification adjustments for realized (gains)/losses(b) (368)477 (94)
(165)501 394
Unrealized holding gains/(losses) on available-for-sale securities, net (846)(640)151
Reclassification adjustments for realized (gains)/losses(b) 796 222 (237)
(50)(418)(86)
Benefit plans: actuarial gains/(losses), net (37)(4,173)3,714
Reclassification adjustments related to amortization(c) 550 195 581
Reclassification adjustments related to settlements, net(c) 671 101 175
Other 199 188 48
1,383 (3,690)4,518
Benefit plans: prior service credits and other, net 432 746 151
Reclassification adjustments related to amortization(c) (160)(73)(58)
Reclassification adjustments related to curtailments, net(c) (32)81
Other (3) (9) (8)
237 672 86
Other comprehensive income/(loss), before tax (1,705) (4,988)4,521
Tax provision/(benefit) on other comprehensive income/(loss)(d) 528 (946)1,928
Other comprehensive income/(loss) before allocation to noncontrolling interests $ (2,232) $(4,042)$ 2,593
Comprehensive income before allocation to noncontrolling interests $4,754 $5,126 $24,665
Less: Comprehensive income/(loss) attributable to noncontrolling interests (1) 36 7
Comprehensive income attributable to Pfizer Inc. $4,755 $5,090 $24,658
(a) Reclassified into Gain on disposal of discontinued operations—net of tax in the consolidated statements of income.
(b) Reclassified into Other (income)/deductions—net in the consolidated statements of income.
(c) Generally reclassified, as part of net periodic pension cost, into Cost of sales, Selling, informational and administrative expenses, and/or Research and
development expenses, as appropriate, in the consolidated statements of income. For additional information, see Note 11. Pension and Postretirement Benefit
Plans and Defined Contribution Plans.
(d) See Note 5E. Tax Matters: Tax Provision/(Benefit) on Other Comprehensive Income/(Loss).
Amounts may not add due to rounding.
See Notes to Consolidated Financial Statements, which are an integral part of these statements.